Literature DB >> 25524901

eIF4E threshold levels differ in governing normal and neoplastic expansion of mammary stem and luminal progenitor cells.

Svetlana Avdulov1, Jeremy Herrera1, Karen Smith1, Mark Peterson1, Jose R Gomez-Garcia1, Thomas C Beadnell2, Kathryn L Schwertfeger3, Alexey O Benyumov1, J Carlos Manivel2, Shunan Li1, Anja-Katrin Bielinsky4, Douglas Yee5, Peter B Bitterman6, Vitaly A Polunovsky6.   

Abstract

Translation initiation factor eIF4E mediates normal cell proliferation, yet induces tumorigenesis when overexpressed. The mechanisms by which eIF4E directs such distinct biologic outputs remain unknown. We found that mouse mammary morphogenesis during pregnancy and lactation is accompanied by increased cap-binding capability of eIF4E and activation of the eIF4E-dependent translational apparatus, but only subtle oscillations in eIF4E abundance. Using a transgenic mouse model engineered so that lactogenic hormones stimulate a sustained increase in eIF4E abundance in stem/progenitor cells of lactogenic mammary epithelium during successive pregnancy/lactation cycles, eIF4E overexpression increased self-renewal, triggered DNA replication stress, and induced formation of premalignant and malignant lesions. Using complementary in vivo and ex vivo approaches, we found that increasing eIF4E levels rescued cells harboring oncogenic c-Myc or H-RasV12 from DNA replication stress and oncogene-induced replication catastrophe. Our findings indicate that distinct threshold levels of eIF4E govern its biologic output in lactating mammary glands and that eIF4E overexpression in the context of stem/progenitor cell population expansion can initiate malignant transformation by enabling cells to evade DNA damage checkpoints activated by oncogenic stimuli. Maintaining eIF4E levels below its proneoplastic threshold is an important anticancer defense in normal cells, with important implications for understanding pregnancy-associated breast cancer. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25524901      PMCID: PMC4333007          DOI: 10.1158/0008-5472.CAN-14-2571

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

Review 1.  Cell-cycle-dependent translational control.

Authors:  S Pyronnet; N Sonenberg
Journal:  Curr Opin Genet Dev       Date:  2001-02       Impact factor: 5.578

2.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap.

Authors:  A Lazaris-Karatzas; K S Montine; N Sonenberg
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

3.  Regulation of initiation factors during translational repression caused by serum depletion. Abundance, synthesis, and turnover rates.

Authors:  R Duncan; J W Hershey
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

4.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Authors:  Vassilis G Gorgoulis; Leandros-Vassilios F Vassiliou; Panagiotis Karakaidos; Panayotis Zacharatos; Athanassios Kotsinas; Triantafillos Liloglou; Monica Venere; Richard A Ditullio; Nikolaos G Kastrinakis; Brynn Levy; Dimitris Kletsas; Akihiro Yoneta; Meenhard Herlyn; Christos Kittas; Thanos D Halazonetis
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

5.  Activation of ras oncogenes preceding the onset of neoplasia.

Authors:  R Kumar; S Sukumar; M Barbacid
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

6.  Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice.

Authors:  Frauke Krepulat; Jürgen Löhler; Christina Heinlein; Andrea Hermannstädter; Genrich V Tolstonog; Wolfgang Deppert
Journal:  Oncogene       Date:  2005-07-07       Impact factor: 9.867

7.  Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells.

Authors:  Svetlana Avdulov; Shunan Li; Van Michalek; David Burrichter; Mark Peterson; David M Perlman; J Carlos Manivel; Nahum Sonenberg; Douglas Yee; Peter B Bitterman; Vitaly A Polunovsky
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

8.  Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice.

Authors:  MaLinda D Henry; Aleata A Triplett; Keon Bong Oh; Gilbert H Smith; Kay-Uwe Wagner
Journal:  Oncogene       Date:  2004-09-09       Impact factor: 9.867

Review 9.  Pregnancy-associated breast cancer and metastasis.

Authors:  Pepper Schedin
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

10.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

Authors:  Hans-Guido Wendel; Elisa De Stanchina; Jordan S Fridman; Abba Malina; Sagarika Ray; Scott Kogan; Carlos Cordon-Cardo; Jerry Pelletier; Scott W Lowe
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

View more
  7 in total

Review 1.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

2.  Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.

Authors:  Columba de la Parra; Luis D Borrero-Garcia; Ailed Cruz-Collazo; Robert J Schneider; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

3.  Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation.

Authors:  Dedra H Fagan; Lynsey M Fettig; Svetlana Avdulov; Heather Beckwith; Mark S Peterson; Yen-Yi Ho; Fan Wang; Vitaly A Polunovsky; Douglas Yee
Journal:  Horm Cancer       Date:  2017-06-02       Impact factor: 3.869

4.  Galeterone and VNPT55 disrupt Mnk-eIF4E to inhibit prostate cancer cell migration and invasion.

Authors:  Andrew K Kwegyir-Afful; Robert D Bruno; Puranik Purushottamachar; Francis N Murigi; Vincent C O Njar
Journal:  FEBS J       Date:  2016-10-01       Impact factor: 5.542

Review 5.  New frontiers in translational control of the cancer genome.

Authors:  Morgan L Truitt; Davide Ruggero
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

Review 6.  Cancer Plasticity: The Role of mRNA Translation.

Authors:  Laura J Lee; David Papadopoli; Michael Jewer; Sonia Del Rincon; Ivan Topisirovic; Mitchell G Lawrence; Lynne-Marie Postovit
Journal:  Trends Cancer       Date:  2020-10-13

7.  Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.

Authors:  Zhong-Ming Feng; Jun Qiu; Xie-Wan Chen; Rong-Xia Liao; Xing-Yun Liao; Lu-Ping Zhang; Xu Chen; Yan Li; Zheng-Tang Chen; Jian-Guo Sun
Journal:  BMC Cancer       Date:  2015-09-23       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.